CD40LG and neoplasm: Overall, transferring the features of the masked IgM antibody in a physiological setting, the blocked antibody is expected to be inert to interactions and interceptions related to IgM in systemic circulation while linker hydrolysis in the tumor microenvironment might result in localized unrestricted binding capacity and robust tumor targeting.